These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15627882)

  • 21. A dark side of interferon-gamma in the treatment of idiopathic pulmonary fibrosis?
    Selman M
    Am J Respir Crit Care Med; 2003 Apr; 167(7):945-6. PubMed ID: 12663333
    [No Abstract]   [Full Text] [Related]  

  • 22. Interferon gamma-1b in the treatment of idiopathic pulmonary fibrosis.
    Pacanowski MA; Amsden GW
    Ann Pharmacother; 2005 Oct; 39(10):1678-86. PubMed ID: 16160001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does interferon-gamma improve pulmonary function in idiopathic pulmonary fibrosis?
    Prasse A; Müller KM; Kurz C; Hamm H; Virchow JC
    Eur Respir J; 2003 Dec; 22(6):906-11. PubMed ID: 14680077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New therapeutic approaches in pulmonary fibrosis].
    Ziesche R; Block LH
    Pneumologie; 2000 Oct; 54(10):431-3. PubMed ID: 11089394
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-cytokine therapy in fibrosing alveolitis: where are we now?
    Millar A
    Respir Res; 2000; 1(1):3-5. PubMed ID: 11667955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New treatments for pulmonary fibrosis?
    Egan JJ
    Lancet; 1999 Nov; 354(9193):1839-40. PubMed ID: 10584718
    [No Abstract]   [Full Text] [Related]  

  • 27. Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis.
    King TE; Safrin S; Starko KM; Brown KK; Noble PW; Raghu G; Schwartz DA
    Chest; 2005 Jan; 127(1):171-7. PubMed ID: 15653980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting impairment of diffusing capacity for Chinese patients with lung fibrosis.
    Leung SK; Lam FM; Yew WW; Wong PC
    Respirology; 2008 Nov; 13(6):929-30. PubMed ID: 18811893
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical characteristics of non-idiopathic pulmonary fibrosis, progressive fibrosing interstitial lung diseases: A single-center retrospective study.
    Komatsu M; Yamamoto H; Kitaguchi Y; Kawakami S; Matsushita M; Uehara T; Kinjo T; Wada Y; Ichiyama T; Urushihata K; Ushiki A; Yasuo M; Hanaoka M
    Medicine (Baltimore); 2021 Apr; 100(13):e25322. PubMed ID: 33787626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute respiratory failure after interferon-gamma therapy in IPF.
    Carvalho CR; Kairalla RA; Schettino GP
    Am J Respir Crit Care Med; 2004 Feb; 169(4):543-4; author reply 544. PubMed ID: 14766665
    [No Abstract]   [Full Text] [Related]  

  • 31. Interferon-gamma1b therapy in idiopathic pulmonary fibrosis: a metaanalysis.
    Bajwa EK; Ayas NT; Schulzer M; Mak E; Ryu JH; Malhotra A
    Chest; 2005 Jul; 128(1):203-6. PubMed ID: 16002936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival in idiopathic pulmonary fibrosis-cytotoxic agents compared to corticosteroids.
    Pereira CA; Malheiros T; Coletta EM; Ferreira RG; Rubin AS; Otta JS; Rocha NS
    Respir Med; 2006 Feb; 100(2):340-7. PubMed ID: 16002271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon gamma-1b for pulmonary fibrosis.
    Fruchter O
    N Engl J Med; 2004 Apr; 350(17):1794-7; author reply 1794-7. PubMed ID: 15106270
    [No Abstract]   [Full Text] [Related]  

  • 34. Penicillamine in the treatment of pulmonary fibrosis.
    Eberl R; Bröll H
    Agents Actions Suppl; 1979; (5):139-48. PubMed ID: 294131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice.
    Langenbach SY; Wheaton BJ; Fernandes DJ; Jones C; Sutherland TE; Wraith BC; Harris T; Schuliga MJ; McLean C; Stewart AG
    Can J Physiol Pharmacol; 2007 Jul; 85(7):727-38. PubMed ID: 17823636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of idiopathic pulmonary fibrosis with histology of usual interstitial pneumonia that responded to pulse therapy followed by combined immunosuppression with prednisolone and azathioprine].
    Shishido M; Ichiki H; Yano M; Toda K; Ohtsuki Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30(12):2139-45. PubMed ID: 1289636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of idiopathic pulmonary fibrosis].
    Dury S
    Rev Mal Respir; 2006 Apr; 23(2 Pt 2):5S87-5S91. PubMed ID: 16788517
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of interferon-gamma treatment on interstitial pneumonia in a patient with severe combined immunodeficiency.
    Kim KH; Kang HY; Kim DS
    Yonsei Med J; 1991 Dec; 32(4):356-61. PubMed ID: 1812657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Glucocorticoids in interstitial lung diseases].
    Schweisfurth H
    Med Klin (Munich); 1993 Jan; 88 Suppl 1():6-7. PubMed ID: 8437537
    [No Abstract]   [Full Text] [Related]  

  • 40. [Strategy of therapy for interstitial lung disease due to chemotherapeutic drugs or radiation].
    Ishioka S
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():432-8. PubMed ID: 9369919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.